- Report
- June 2025
- 400 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- June 2025
- 400 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- May 2023
- 147 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- May 2025
- 84 Pages
United States
From €3136EUR$3,500USD£2,686GBP
- Report
- July 2025
- 350 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- July 2025
- 350 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- July 2025
- 350 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- July 2025
- 350 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- June 2025
- 400 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- April 2024
- 140 Pages
Global
From €4452EUR$4,969USD£3,814GBP
- Report
- May 2023
- 140 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- May 2024
- 124 Pages
Global
From €3539EUR$3,950USD£3,032GBP
- Report
- January 2022
- 132 Pages
Global
From €3987EUR$4,450USD£3,415GBP
- Report
- August 2025
- 150 Pages
Global
From €2831EUR$3,160USD£2,425GBP
€3539EUR$3,950USD£3,032GBP
- Report
- August 2025
- 150 Pages
Global
From €2760EUR$3,080USD£2,364GBP
€3450EUR$3,850USD£2,955GBP
- Report
- September 2025
- 150 Pages
Canada
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2025
- 150 Pages
Global
From €4346EUR$4,850USD£3,722GBP
- Report
- January 2021
- 245 Pages
Global
From €3226EUR$3,600USD£2,763GBP
- Report
- July 2025
- 274 Pages
Global
From €4476EUR$4,995USD£3,834GBP
- Report
- May 2025
- 145 Pages
United States
From €2240EUR$2,500USD£1,919GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more